Mirjana Urosevic
Department of Dermatology
University Hospital Zurich
8091 Zurich
Switzerland
Name/email consistency: high
- Human leukocyte antigen-G and cancer immunoediting. Urosevic, M., Dummer, R. Cancer Res. (2008)
- HLA-G in the skin--friend or foe? Urosevic, M. Semin. Cancer Biol. (2007)
- Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomas. Urosevic, M. Curr. Opin. Investig. Drugs (2007)
- Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas. Urosevic, M., Fujii, K., Calmels, B., Laine, E., Kobert, N., Acres, B., Dummer, R. J. Clin. Invest. (2007)
- Expression of melanoma-associated antigens in melanoma cell cultures. Urosevic, M., Braun, B., Willers, J., Burg, G., Dummer, R. Exp. Dermatol. (2005)
- HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Urosevic, M., Kempf, W., Zagrodnik, B., Panizzon, R., Burg, G., Dummer, R. Clin. Exp. Dermatol. (2005)
- Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. Urosevic, M., Dummer, R., Conrad, C., Beyeler, M., Laine, E., Burg, G., Gilliet, M. J. Natl. Cancer Inst. (2005)
- CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Urosevic, M., Conrad, C., Kamarashev, J., Asagoe, K., Cozzio, A., Burg, G., Dummer, R. Hum. Pathol. (2005)
- Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Urosevic, M., Kamarashev, J., Burg, G., Dummer, R. Blood (2004)
- HLA-G in skin cancer: a wolf in sheep's clothing?. Urosevic, M., Dummer, R. Hum. Immunol. (2003)
- HLA-G and IL-10 expression in human cancer--different stories with the same message. Urosevic, M., Dummer, R. Semin. Cancer Biol. (2003)